Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics

Mazyar Shadman, MD, MPH, Sarah Gibson, MD, Claudiu Cotta, MD, Yogen Saunthararajah, MD, Eric Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Meagan Effinger, BA, Anjali S. Advani, MD

Blood (2010) 116 (21): 2736.

https://doi.org/10.1182/blood.V116.21.2736.2736

Published: 2010

Journal Articles

Expression of Phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) Is Associated with An Increased Risk of Death In Acute Myeloid Leukemia.

Anna Brady, MD, Sarah Gibson, MD, Lisa Rybicki, MS, Eric Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Yogen Saunthararajah, MD, Jennifer Bates, Anjali S. Advani, MD

Blood (2010) 116 (21): 1675.

https://doi.org/10.1182/blood.V116.21.1675.1675

Published: 2010

Journal Articles

Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML).

Mazyar Shadman, MD, MPH, Sarah Gibson, MD, Claudiu Cotta, MD, PhD, Eric D. Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Yogen Saunthararajah, M.D., Meagan Effinger, B.A., Anjali Advani, MD

Blood (2009) 114 (22): 4681.

https://doi.org/10.1182/blood.V114.22.4681.4681

Published: 2009

Journal Articles

Histone H4 Acetylation as a Prognostic Factor for Patients with Acute Lymphocytic Leukemia in First Relapse.

Anjali Advani, MD, Sarah Gibson, MD, Elizabeth Douglas, MD, Tao Jin, Matt Kalaycio, MD, Edward A. Copelan, MD, Mikkael A Sekeres, MD, MS, Ronald Sobecks, MD, Shawnda Sungren, Eric Hsi, MD

Blood (2008) 112 (11): 1482.

https://doi.org/10.1182/blood.V112.11.1482.1482

Published: 2008

Journal Articles

OCT-2 Expression and OCT-2/BOB.1 Co-Expression Predict Prognosis in Patients with Newly Diagnosed Acute Myelogenous Leukemia.

Kathleen Lim, MD, Sarah Gibson, MD, Tao Jin, Eric Hsi, MD, Matt Kalaycio, MD, Edward A. Copelan, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Anjali Advani, MD

Blood (2008) 112 (11): 1486.

https://doi.org/10.1182/blood.V112.11.1486.1486

Published: 2008

Journal Articles

Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics.

Anjali S. Advani, MD, Sarah Gibson, MD, Tao Jin, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael A. Sekeres, MD, Ed Copelan, MD, Shawnda Sungren, BBA, Eric D. Hsi, MD

Blood (2007) 110 (11): 2798.

https://doi.org/10.1182/blood.V110.11.2798.2798

Published: 2007

Journal Articles

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

Anjali S. Advani, MD, Sarah Gibson, MD, Tao Jin, MS, Ramon Tiu, MD, Giridharan Ramsingh, MD, Matt Kalaycio, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Shawnda Sungren, BBA, Eric D. Hsi, MD

Blood (2006) 108 (11): 1846.

https://doi.org/10.1182/blood.V108.11.1846.1846

Published: 2006

NARROW

Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics

Expression of Phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) Is Associated with An Increased Risk of Death In Acute Myeloid Leukemia.

Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML).

Histone H4 Acetylation as a Prognostic Factor for Patients with Acute Lymphocytic Leukemia in First Relapse.

OCT-2 Expression and OCT-2/BOB.1 Co-Expression Predict Prognosis in Patients with Newly Diagnosed Acute Myelogenous Leukemia.

Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics.

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics

Expression of Phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) Is Associated with An Increased Risk of Death In Acute Myeloid Leukemia.

Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML).

Histone H4 Acetylation as a Prognostic Factor for Patients with Acute Lymphocytic Leukemia in First Relapse.

OCT-2 Expression and OCT-2/BOB.1 Co-Expression Predict Prognosis in Patients with Newly Diagnosed Acute Myelogenous Leukemia.

Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics.

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only